Requirement for Etoposide in the Treatment of Epstein-Barr Virus–Associated Hemophagocytic Lymphohistiocytosis

2001285 citationsJournal Article

Authors

We conclude that early administration of etoposide, preferably with CSA, is the treatment of choice for patients with EBV-HLH.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 19, Issue 10, pp. 2665-2673

Field-Weighted Citation Impact: 3.46